MALAT1 and type 2 diabetes mellitus: Decreased circulating Oment-1 levels and elevated MALAT1 expression are significantly associated with CHD in patients with T2DM, suggesting their potential as biomarkers for the noninvasive early detection of CHD in T2DM patients.